Search
CELL BANK Website

Back Back
RCB2095 : PANC-1  update : 2020/02/06
CommentHuman cell line derived from pancreatic cancer. Ductal origin. TKG0606 (Deposited from Tohoku Univ.).
Comment from the depositor
Terms and conditionsBasically, there is no restriction regarding academic use.
Remarks
Order Form Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC(cellbank.brc@riken.jp) regarding any kind of for-profit use.
Basic information Depositor Obinata, Masuo
Year of deposit 2005
Original cell TKG0606
Animal human < Mammals
Genus Homo
Species sapiens
Gender Unknown
Tissue pancreas
Case history Pancreaticcarcinoma of ductal origin
Classification cancer
History Cell Resource Center for Biomedical Research, Tohoku University(TKG0606)
Lifespan infinite
Morphology epithelial-like
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Medium and additives RPMI1640 + 10% FBS
Antibiotics Free
Passage method 0.25% trypsin + 0.02% EDTA
Culture information Passage ratio 1 : 4-8 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
STR (human) OK
Animal PCR OK
Images
deposit info
lot info
Reference information Reference 3
User's Publication 68


To topTop
Reference
3459  Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas.  Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G  Int J Cancer  1975  15:741-7  PubMed ID: 1140870
3301  Growth inhibition of human pancreatic cancer cells by sphingosylphosphorylcholine and influence of culture conditions.  Yamada T, Okajima F, Ohwada S, Kondo Y  Cell Mol Life Sci  1997  53:435-41  PubMed ID: 9176562
5077  Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase.  Wu MC, Arimura GK, Yunis AA.  Int J Cancer  1978  22(6):728-33  PubMed ID: 363626

To topTop
User's Publication
7168  Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer.  Miyamae M, Komatsu S, Ichikawa D, Kawaguchi T, Hirajima S, Okajima W, Ohashi T, Imamura T, Konishi H, Shiozaki A, Morimura R, Ikoma H, Ochiai T, Okamoto K, Taniguchi H, Otsuji E.  Br. J. Cancer  2015  113:1467-76  PubMed ID: 26505678
7235  The PTB-Associated Splicing Factor/Peroxisome Proliferator-Activated Receptor Gamma Axis Regulates Autophagosome Formation in Human Pancreatic Cancer Cells.  Tsukahara T, Haniu H, Matsuda Y.  Biores Open Access  2015  4:319-25  PubMed ID: 26309807
7318  Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.  Douchi D, Ohtsuka H, Ariake K, Masuda K, Kawasaki S, Kawaguchi K, Fukase K, Oikawa M, Motoi F, Naitoh T, Katayose Y, Egawa S, Unno M.  Cancer Lett.  2015  365:132-40  PubMed ID: 26047573
7331  Cancer stem cell marker-expressing cell-rich spheroid fabrication from PANC-1 cells using alginate microcapsules with spherical cavities templated by gelatin microparticles.  Sakai S, Inamoto K, Ashida T, Takamura R, Taya M.  Biotechnol. Prog.  2015  31:1071-6  PubMed ID: 26013961
7400  Clinical significance of CD155 expression in human pancreatic cancer.  Nishiwada S, Sho M, Yasuda S, Shimada K, Yamato I, Akahori T, Kinoshita S, Nagai M, Konishi N, Nakajima Y.  Anticancer Res.  2015  35:2287-97  PubMed ID: 25862891
7560  Standard WT1 Expression Using Immunohistochemistry.  Shimodaira S, Hirabayashi K, Koya T, Higuchi Y, Sano K  J Mol Biomark Diagn  2015  7:266 
7643  Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.  Morimura R, Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Nagata H, Konishi H, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E.  Br. J. Cancer  2011  105:1733-40  PubMed ID: 22045190
7858  Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with β-catenin in tumor progression.  Xu H, Inagaki Y, Seyama Y, Hasegawa K, Sugawara Y, Du G, Wang F, Tang W, Kokudo N.  Life Sci.  2011  88:1063-9  PubMed ID: 21466814
7928  The CD40-CD154 interaction would correlate with proliferation and immune escape in pancreatic ductal adenocarcinoma.  Shoji Y, Miyamoto M, Ishikawa K, Yoshioka T, Mishra R, Ichinokawa K, Matsumura Y, Itoh T, Shinohara T, Hirano S, Kondo S.  J Surg Oncol  2011  103:230-8  PubMed ID: 21337550
7984  A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells.  Tomita Y, Imai K, Senju S, Irie A, Inoue M, Hayashida Y, Shiraishi K, Mori T, Daigo Y, Tsunoda T, Ito T, Nomori H, Nakamura Y, Kohrogi H, Nishimura Y.  Cancer Sci.  2011  102:697-705  PubMed ID: 21231984
8292  Human Arm protein lost in epithelial cancers, on chromosome X 1 (ALEX1) gene is transcriptionally regulated by CREB and Wnt/beta-catenin signaling.  Iseki H, Takeda A, Andoh T, Takahashi N, Kurochkin IV, Yarmishyn A, Shimada H, Okazaki Y, Koyama I.  Cancer Sci.  2010  101:1361-6  PubMed ID: 20398052
8294  Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer.  Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.  World J. Gastroenterol.  2010  16:1854-8  PubMed ID: 20397262
9568  Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL.  Chijiiwa Y, Moriyama T, Ohuchida K, Nabae T, Ohtsuka T, Miyasaka Y, Fujita H, Maeyama R, Manabe T, Abe A, Mizuuchi Y, Oda Y, Mizumoto K, Nakamura M.  Int. J. Oncol.  2016  48:1688-700  PubMed ID: 26892887
9592  Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma.  Hijiya N, Tsukamoto Y, Nakada C, Tung Nguyen L, Kai T, Matsuura K, Shibata K, Inomata M, Uchida T, Tokunaga A, Amada K, Shirao K, Yamada Y, Mori H, Takeuchi I, Seto M, Aoki M, Takekawa M, Moriyama M.  Cancer Res.  2016  76:2612-25  PubMed ID: 26941286
9624  Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification.  Itonaga M, Matsuzaki I, Warigaya K, Tamura T, Shimizu Y, Fujimoto M, Kojima F, Ichinose M, Murata S.  PLoS ONE  2016  11:e0151654  PubMed ID: 26999437
9748  N-Methylniphatyne A, a New 3-Alkylpyridine Alkaloid as an Inhibitor of the Cancer Cells Adapted to Nutrient Starvation, from an Indonesian Marine Sponge of Xestospongia sp.  Arai M, Kamiya K, Shin D, Matsumoto H, Hisa T, Setiawan A, Kotoku N, Kobayashi M.  Chem. Pharm. Bull.  2016  64:766-71  PubMed ID: 27373630
9761  Marine spongean polybrominated diphenyl ethers, selective growth inhibitors against the cancer cells adapted to glucose starvation, inhibits mitochondrial complex II.  Arai M, Shin D, Kamiya K, Ishida R, Setiawan A, Kotoku N, Kobayashi M.  J Nat Med  2017  71:44-49  PubMed ID: 27449332
9938  CASTIN: a system for comprehensive analysis of cancer-stromal interactome.  Komura D, Isagawa T, Kishi K, Suzuki R, Sato R, Tanaka M, Katoh H, Yamamoto S, Tatsuno K, Fukayama M, Aburatani H, Ishikawa S.  BMC Genomics  2016  17:899  PubMed ID: 27829362
9958  FOXO3 is essential for CD44 expression in pancreatic cancer cells.  Kumazoe M, Takai M, Bae J, Hiroi S, Huang Y, Takamatsu K, Won Y, Yamashita M, Hidaka S, Yamashita S, Yamada S, Murata M, Tsukamoto S, Tachibana H.  Oncogene  2017  36:2643-2654  PubMed ID: 27893718
10031  Amino-group carrier-protein-mediated secondary metabolite biosynthesis in Streptomyces.  Hasebe F, Matsuda K, Shiraishi T, Futamura Y, Nakano T, Tomita T, Ishigami K, Taka H, Mineki R, Fujimura T, Osada H, Kuzuyama T, Nishiyama M.  Nat. Chem. Biol.  2016  12:967-972  PubMed ID: 28288097
10046  Cancer-associated peritoneal mesothelial cells lead the formation of pancreatic cancer peritoneal dissemination.  Abe T, Ohuchida K, Koikawa K, Endo S, Okumura T, Sada M, Horioka K, Zheng B, Moriyama T, Nakata K, Miyasaka Y, Manabe T, Ohtsuka T, Nagai E, Mizumoto K, Hashizume M, Nakamura M.  Int. J. Oncol.  2017  50:457-467  PubMed ID: 28035373
10053  Highly versatile SPION encapsulated PLGA nanoparticles as photothermal ablators of cancer cells and as multimodal imaging agents.  Sivakumar B, Aswathy RG, Romero-Aburto R, Mitcham T, Mitchel KA, Nagaoka Y, Bouchard RR, Ajayan PM, Maekawa T, Sakthikumar DN.  Biomater Sci  2017  5:432-443  PubMed ID: 28059418
10086  Constituents of the Rhizomes of Boesenbergia pandurata and Their Antiausterity Activities against the PANC-1 Human Pancreatic Cancer Line.  Nguyen NT, Nguyen MT, Nguyen HX, Dang PH, Dibwe DF, Esumi H, Awale S.  J. Nat. Prod.  2017  80:141-148  PubMed ID: 28099006
10311  The FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma.  Kumazoe M, Takai M, Hiroi S, Takeuchi C, Kadomatsu M, Nojiri T, Onda H, Bae J, Huang Y, Takamatsu K, Yamashita S, Kangawa K, Tachibana H.  J. Biol. Chem.  2017  292:10813-10823  PubMed ID: 28507102
10337  The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.  Iwata T, Uchino T, Koyama A, Johmura Y, Koyama K, Saito T, Ishiguro S, Arikawa T, Komatsu S, Miyachi M, Sano T, Nakanishi M, Shimada M.  PLoS ONE  2017  12:e0178221  PubMed ID: 28558031
10399  In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.  Fujita M, Hasegawa A, Yamamori M, Okamura N.  J. Exp. Clin. Cancer Res.  2017  36:91  PubMed ID: 28673319
10448  Efficient Synthesis of Heterocyclic Flavonoids with Hedgehog Signal Inhibitory Activity.  Arai MA, Utsumi T, Yanase N, Fujimatsu T, Ishibashi M.  Chem. Pharm. Bull.  2017  65:784-795  PubMed ID: 28768932
10481  Autophagy inhibition enhances antiproliferative effect of salinomycin in pancreatic cancer cells.  Endo S, Nakata K, Sagara A, Koikawa K, Ando Y, Kibe S, Takesue S, Nakayama H, Abe T, Okumura T, Moriyama T, Miyasaka Y, Ohuchida K, Ohtsuka T, Mizumoto K, Nakamura M.  Pancreatology  2017  17:990-996  PubMed ID: 28927939
10537  Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells.  Kawamura D, Takemoto Y, Nishimoto A, Ueno K, Hosoyama T, Shirasawa B, Tanaka T, Kugimiya N, Harada E, Hamano K.  Oncol. Rep.  2017  38:3238-3244  PubMed ID: 29048622
10563  Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180.  Koikawa K, Ohuchida K, Takesue S, Ando Y, Kibe S, Nakayama H, Endo S, Abe T, Okumura T, Horioka K, Sada M, Iwamoto C, Moriyama T, Nakata K, Miyasaka Y, Ohuchida R, Manabe T, Ohtsuka T, Nagai E, Mizumoto K, Hashizume M, Nakamura M.  Cancer Lett.  2018  412:143-154  PubMed ID: 29061505
11010  Ancistrolikokines E–H and related 5,8′-coupled naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus likoko with antiausterity activities against PANC-1 human pancreatic cancer cells    RSC Adv.  2017  7, 53740-53751 
11140  Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis.  Akimoto M, Maruyama R, Kawabata Y, Tajima Y, Takenaga K.  Cell Death Dis  2018  9(8):804  PubMed ID: 30038429
11190  Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix.  Okumura T, Ohuchida K, Kibe S, Iwamoto C, Ando Y, Takesue S, Nakayama H, Abe T, Endo S, Koikawa K, Sada M, Horioka K, Mochidome N, Arita M, Moriyama T, Nakata K, Miyasaka Y, Ohtsuka T, Mizumoto K, Oda Y, Hashizume M, Nakamura M.  Int. J. Cancer  2019  144(6):1401-1413  PubMed ID: 30152542
4453  Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3p.  Idichi T, Seki N, Kurahara H, Fukuhisa H, Toda H, Shimonosono M, Yamada Y, Arai T, Kita Y, Kijima Y, Mataki Y, Maemura K, Natsugoe S.  Oncotarget  2018  9(48):28849-28865  PubMed ID: 29988949
11218  Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.  Arima K, Ohmuraya M, Miyake K, Koiwa M, Uchihara T, Izumi D, Gao F, Yonemura A, Bu L, Okabe H, Imai K, Hashimoto D, Baba Y, Chikamoto A, Yamashita YI, Furukawa T, Araki K, Baba H, Ishimoto T.  Oncogene  2018    PubMed ID: 30250298
11436  CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.  Yan Z, Ohuchida K, Zheng B, Okumura T, Takesue S, Nakayama H, Iwamoto C, Shindo K, Moriyama T, Nakata K, Miyasaka Y, Ohtsuka T, Mizumoto K, Oda Y, Hashizume M, Nakamura M.  J. Cancer Res. Clin. Oncol.  2019    PubMed ID: 30770989
11483  Gene Regulation by Antitumor miR-204-5p in Pancreatic Ductal Adenocarcinoma: The Clinical Significance of Direct RACGAP1 Regulation.  Khalid M, Idichi T, Seki N, Wada M, Yamada Y, Fukuhisa H, Toda H, Kita Y, Kawasaki Y, Tanoue K, Kurahara H, Mataki Y, Maemura K, Natsugoe S.  Cancers (Basel)  2019    PubMed ID: 30866526
11480  Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.  Fukuhisa H, Seki N, Idichi T, Kurahara H, Yamada Y, Toda H, Kita Y, Kawasaki Y, Tanoue K, Mataki Y, Maemura K, Natsugoe S.  J. Hum. Genet.  2019    PubMed ID: 30858505
4216  Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction.  Feng R, Morine Y, Ikemoto T, Imura S, Iwahashi S, Saito Y, Shimada M.  Cell Commun. Signal  2018    PubMed ID: 30180849
4314  DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.  Katase N, Nishimatsu SI, Yamauchi A, Yamamura M, Terada K, Itadani M, Okada N, Hassan NMM, Nagatsuka H, Ikeda T, Nohno T, Fujita S.  Oncol. Res.  2018    PubMed ID: 28470144
4382  Ancistroyafungines A-D, 5,8'- and 5,1'-coupled naphthylisoquinoline alkaloids from a Congolese Ancistrocladus species, with antiausterity activities against human PANC-1 pancreatic cancer cells.  Kavatsurwa SM, Lombe BK, Feineis D, Dibwe DF, Maharaj V, Awale S, Bringmann G.  Fitoterapia  2018    PubMed ID: 30059720
4383  Alternating magnetic field enhances cytotoxicity of Compound C.  Akimoto T, Umemura M, Nagasako A, Ohtake M, Fujita T, Yokoyama U, Eguchi H, Yamamoto T, Ishikawa Y.  Cancer Sci.  2018  109(11):3483-3493  PubMed ID: 30155931
4481  Michellamines A6 and A7, and further mono- and dimeric naphthylisoquinoline alkaloids from a Congolese Ancistrocladus liana and their antiausterity activities against pancreatic cancer cells  Blaise Kimbadi Lombe, Doris Feineis, Virima Mudogo, Reto Brun, Suresh Awale and Gerhard Bringmann  RSC Adv  2018  8:5243 
4494  Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer.  Inoko K, Hiraoka K, Inagaki A, Takahashi M, Kushibiki T, Hontani K, Takano H, Sato S, Takeuchi S, Nakamura T, Tsuchikawa T, Shichinohe T, Gruber HE, Jolly DJ, Kasahara N, Hirano S.  Cancer Gene Ther.  2018  25(7-8):184-195  PubMed ID: 29735994
5018  Frizzled-2: A potential novel target for molecular pancreatic cancer therapy.  Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.  Oncol Lett  2014  7(1):74-78  PubMed ID: 24348824
5019  SU11274 suppresses proliferation and motility of pancreatic cancer cells.  Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N.  Oncol Lett  2015  10(3):1468-1472  PubMed ID: 26622692
5020  nsulin-like growth factor I receptor involvement in proliferation of NOR-P1 cells in serum-free media.  Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.  J Cell Biochem  2012  113(8):2714-20  PubMed ID: 22441995
5024  Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer.  Kawaguchi T, Komatsu S, Ichikawa D, Morimura R, Tsujiura M, Konishi H, Takeshita H, Nagata H, Arita T, Hirajima S, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H, Otsuji E.  Br J Cancer  2013  108(2):361-9  PubMed ID: 23329235
5025  Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.  Sakamoto K, Imai K, Higashi T, Taki K, Nakagawa S, Okabe H, Nitta H, Hayashi H, Chikamoto A, Ishiko T, Beppu T, Baba H.  Cancer Sci  2015  106(9):1153-62  PubMed ID: 26132727
5027  Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.  Nishizawa N1, Harada H1, Kumamoto Y1, Kaizu T, Katoh H, Tajima H, Ushiku H, Yokoi K, Igarashi K, Fujiyama Y, Okuwaki K, Iwai T, Watanabe M, Yamashita K1  Cancer Sci  2019  110(9):2846-2855  PubMed ID: 31325200
5032  Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.  Igarashi S, Matsubara T, Harada K, Ikeda H, Sato Y, Sasaki M, Matsui O, Nakanuma Y.  Histopathology  2012  61(2):266-76  PubMed ID: 22594685
5446  Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice.  Endo S1, Nakata K2, Ohuchida K3, Takesue S1, Nakayama H1, Abe T1, Koikawa K, Okumura T, Sada M, Horioka K, Zheng B, Mizuuchi Y, Iwamoto C5, Murata M, Moriyama T, Miyasaka Y, Ohtsuka T, Mizumoto K, Oda Y, Hashizume M, Nakamura M  Gastroenterology  2017  152(6):1492-1506  PubMed ID: 28126348
3714  Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.  Kato N, Yamamoto H, Adachi Y, Ohashi H, Taniguchi H, Suzuki H, Nakazawa M, Kaneto H, Sasaki S, Imai K, Shinomura Y.  World J Gastroenterol  2013  19(11):1718-27  PubMed ID: 23555160
5802  Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment.  Eguchi T et al  PLoS One  2018  13(2):e0191109.  PubMed ID: 29415026
5875  Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.  Mishra R, Miyamoto M, Yoshioka T, Ishikawa K, Matsumura Y, Shoji Y, Ichinokawa K, Itoh T, Shichinohe T, Hirano S, Kondo S.  Int J Oncol  2009  34(5):1231-40  PubMed ID: 19360336
11571  S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer.  Nakayama H, Ohuchida K, Yonenaga A, Sagara A, Ando Y, Kibe S, Takesue S, Abe T, Endo S, Koikawa K, Okumura T, Shido K, Miyoshi K, Nakata K, Moriyama T, Miyasaka Y, Inoue S, Ohtsuka T, Mizumoto K, Nakamura M.  Int. J. Oncol.  2019    PubMed ID: 31180531
11575  Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.  Yan Z, Ohuchida K, Fei S, Zheng B, Guan W, Feng H, Kibe S, Ando Y, Koikawa K, Abe T, Iwamoto C, Shindo K, Moriyama T, Nakata K, Miyasaka Y, Ohtsuka T, Mizumoto K, Hashizume M, Nakamura M.  J. Exp. Clin. Cancer Res.  2019    PubMed ID: 31133044
11685  Effect of 5-aminolevulinic acid on the haem biosynthesis pathway in pancreatic cancer and pancreatic ductal epithelial cell lines  Peter L. Labib, Walid Al-Akkad, Brian R. Davidson, Alexander J. MacRobert, Stephen P. Pereira  17th International Photodynamic Association World Congress  2019   
11686  Targeting of epidermal growth factor receptor (EGFR)-positive pancreatic cancer cell lines with cetuximab-conjugated near-infrared silver sulphide quantum dots  Peter L. Labib, Elnaz Yaghini, Mahshid Hashemkhani, Brian R. Davidson, Alexander J. MacRobert, Marilena Loizidou, Havva Y. Acar, Stephen P. Pereira  17th International Photodynamic Association World Congress  2019   
11687  5-aminolevulinic acid as a potential contrast agent for image-guided surgery in pancreatic cancer  Peter L. Labib, Elnaz Yaghini, Brian R. Davidson, Alexander J. MacRobert, Stephen P. Pereira  17th International Photodynamic Association World Congress  2019   
11767  Selective cytotoxicity of epidithiodiketopiperazine DC1149B, produced by marine-derived Trichoderma lixii on the cancer cells adapted to glucose starvation.  Tang R, Kimishima A, Ishida R, Setiawan A, Arai M.  J Nat Med  2019    PubMed ID: 31435860
11779  Liraglutide suppresses the metastasis of PANC-1 co-cultured with pancreatic stellate cells through modulating intracellular calcium content.  Zhao H, Jiang X, Duan L, Yang L, Wang W, Ren Z.  Endocr. J.  2019    PubMed ID: 31474673
11811  Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer.  Mohammad GH, Vassileva V, Acedo P, Olde Damink SWM, Malago M, Dhar DK, Pereira SP.  Cancers (Basel)  2019    PubMed ID: 31527446
11836  Targeted Proteomics-Based Quantitative Protein Atlas of Pannexin and Connexin Subtypes in Mouse and Human Tissues and Cancer Cell Lines.  Tachikawa M, Kaneko Y, Ohtsuki S, Uchida Y, Watanabe M, Ohtsuka H, Terasaki T.  J Pharm Sci  2019    PubMed ID: 31605689
11851  Silencing of Glutathione S-Transferase Pi Inhibits Cancer Cell Growth via Oxidative Stress Induced by Mitochondria Dysfunction.  Fujitani N, Yoneda A, Takahashi M, Takasawa A, Aoyama T, Miyazaki T.  Sci Rep  2019    PubMed ID: 31611630
6913  Highly active copper(I) complexes of aroylthiourea ligands against cancer cells – synthetic and biological studies  Kumaramangalam Jeyalakshmi, et al  New J Chem  2019  43:3188 
6956  BACH1 promotes pancreatic cancer metastasis by repressing epithelial genes and enhancing epithelial-mesenchymal transition.  Sato M, Matsumoto M, Saiki Y, Alam M, Nishizawa H, Rokugo M, Brydun A, Yamada S, Kaneko MK, Funayama R, Ito M, Kato Y, Nakayama K, Unno M, Igarashi K.  Cancer Res  2020    PubMed ID: 31919242
6410  Is parainfluenza virus a threatening virus for human cancer cell lines?  Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.  Hum Cell  2009  22(3):81-4  PubMed ID: 19624309



Back Back Return Top Page